Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06000696 · ClinicalTrials.gov registry record

Healthy At Home Pilot

A clinical trial of COPD and Emphysema or COPD, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
100
Enrollment target
1
Study location

NCT06000696: Completed study of COPD and Emphysema or COPD, sponsored by University of Massachusetts, Worcester.

NCT06000696 is a study of COPD and Emphysema or COPD that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 100 participants, below the 2,417-participant average among 85 other COPD trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06000696, a study of COPD and Emphysema or COPD, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The objective is to conduct a pilot-feasibility trial of the "Healthy at Home" program, a multimodal intervention aimed at preventing acute care needs among COPD patients. The program will feature a digital platform and virtual pulmonary rehabilitation to facilitate complex care management of UMass Memorial Health Patients

Primary Outcome

Develop and use a smartphone app to enroll 100 UMass Memorial Health patients into the Healthy at Home program based on their short-term risk of requiring acute care needs.

Study Locations (1)

Massachusetts

  • UMass Chan Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-09-09
Est. Completion 2024-08-30

What the finished NCT06000696 record still lists

NCT06000696 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,417-participant average among 85 other COPD trials with a reported enrollment target (96% lower).

The record links to 3 conditions, with COPD appearing as the primary indexed condition, and to 0 interventions.

NCT06000696 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06000696 about?

NCT06000696 is a clinical study titled "Healthy At Home Pilot". The objective is to conduct a pilot-feasibility trial of the "Healthy at Home" program, a multimodal intervention aimed at preventing acute care needs among COPD patients. The program will feature a digital platform and virtual pulmonary rehabilitation to facilitate complex care management of UMass ...

What is the current status of trial NCT06000696?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2022-09-09. Estimated completion is 2024-08-30.

What conditions does trial NCT06000696 study?

This clinical trial studies the following conditions: COPD, Emphysema or COPD, COPD Exacerbation.

Who is sponsoring clinical trial NCT06000696?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06000696 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06000696's enrollment target sits among peer trials

100 38th of 85 higher than 47 of 85 other COPD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06000696, the US trial registry maintained by the National Library of Medicine. NCT06000696 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.